MQS Management LLC Buys New Shares in McKesson Corporation $MCK

MQS Management LLC purchased a new position in McKesson Corporation (NYSE:MCK) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 628 shares of the company’s stock, valued at approximately $485,000.

Several other institutional investors have also added to or reduced their stakes in MCK. Baader Bank Aktiengesellschaft bought a new stake in shares of McKesson in the 3rd quarter valued at about $437,000. Versor Investments LP lifted its position in McKesson by 18.8% in the third quarter. Versor Investments LP now owns 701 shares of the company’s stock valued at $542,000 after purchasing an additional 111 shares during the last quarter. Johnson Investment Counsel Inc. lifted its position in McKesson by 4.0% in the third quarter. Johnson Investment Counsel Inc. now owns 2,014 shares of the company’s stock valued at $1,556,000 after purchasing an additional 78 shares during the last quarter. Hopwood Financial Services Inc. purchased a new stake in shares of McKesson during the third quarter valued at approximately $31,000. Finally, Prospera Financial Services Inc grew its holdings in shares of McKesson by 21.8% in the third quarter. Prospera Financial Services Inc now owns 7,804 shares of the company’s stock worth $6,031,000 after purchasing an additional 1,398 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on MCK. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. TD Cowen boosted their price target on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. JPMorgan Chase & Co. upped their price target on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, Mizuho lifted their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $937.07.

Insider Transactions at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The SEC filing for this sale provides additional information. 0.08% of the stock is currently owned by corporate insiders.

McKesson Stock Up 1.8%

NYSE MCK opened at $951.91 on Thursday. The firm has a market capitalization of $116.60 billion, a PE ratio of 27.38, a P/E/G ratio of 1.51 and a beta of 0.40. The stock’s 50 day moving average is $835.56 and its 200 day moving average is $785.04. McKesson Corporation has a twelve month low of $585.22 and a twelve month high of $971.93.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. During the same quarter last year, the firm posted $8.03 earnings per share. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson’s payout ratio is presently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.